+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Targeted Therapies"

Biospecific Antibody Market Analysis & Forecast to 2023-2033: Market By Drug Type; By Indication; By Distribution Channel; and by Region - Product Thumbnail Image

Biospecific Antibody Market Analysis & Forecast to 2023-2033: Market By Drug Type; By Indication; By Distribution Channel; and by Region

  • Report
  • July 2023
  • 145 Pages
  • Global
From
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • March 2024
  • 174 Pages
  • Global
From
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

CAR T-Cell Therapy for Non-Hodgkin's Lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • February 2024
  • 200 Pages
  • Global
From
T-Cell Receptor (TCR) Therapy - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

T-Cell Receptor (TCR) Therapy - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • May 2023
  • 200 Pages
  • Global
From
United States LY3484356 (Imlunestrant) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States LY3484356 (Imlunestrant) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
CAEL-101 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CAEL-101 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Braftovi (encorafenib) + Erbitux (cetuximab) + Mektovi (binimetinib) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Braftovi (encorafenib) + Erbitux (cetuximab) + Mektovi (binimetinib) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
EMPAVELI/ASPAVELI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EMPAVELI/ASPAVELI Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • September 2022
  • 30 Pages
  • Global
From
South & Central America Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - Regional Analysis - by Service Type and End-User - Product Thumbnail Image

South & Central America Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - Regional Analysis - by Service Type and End-User

  • Report
  • January 2024
  • 95 Pages
From
Microbiome Therapeutics Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Type, Application, End User, and Geography - Product Thumbnail Image

Microbiome Therapeutics Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Type, Application, End User, and Geography

  • Report
  • November 2023
  • 160 Pages
  • Global
From
Gene Therapy-Competitive landscape, 2023 - Product Thumbnail Image

Gene Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Europe Microbiome Therapeutics Market Forecast to 2030 - Regional Analysis - by Type, Application, and End User - Product Thumbnail Image

Europe Microbiome Therapeutics Market Forecast to 2030 - Regional Analysis - by Type, Application, and End User

  • Report
  • April 2024
  • 71 Pages
  • Europe
From
North America Microbiome Therapeutics Market Forecast to 2030 - Regional Analysis - by Type, Application, and End User - Product Thumbnail Image

North America Microbiome Therapeutics Market Forecast to 2030 - Regional Analysis - by Type, Application, and End User

  • Report
  • April 2024
  • 68 Pages
  • North America
From
CRISPR Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

CRISPR Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Gene Therapy in Ophthalmology - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Gene Therapy in Ophthalmology - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2024
  • 225 Pages
  • Global
From
Adeno-Associated Virus Vectors in Gene Therapy - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Adeno-Associated Virus Vectors in Gene Therapy - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Bio-pharma Market 2024-2028 - Product Thumbnail Image

Bio-pharma Market 2024-2028

  • Report
  • December 2023
  • 184 Pages
  • Global
From
UAE Pharmaceutical CRO Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

UAE Pharmaceutical CRO Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • January 2025
  • 82 Pages
  • United Arab Emirates United Arab Emirates
From
Biopharmaceutical Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Biopharmaceutical Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • April 2024
  • 180 Pages
  • Global
From
Biologics Contract Development Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Biologics Contract Development Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Loading Indicator

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments. The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more